InvestorsHub Logo
Followers 13
Posts 1546
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Tuesday, 08/11/2020 6:38:58 PM

Tuesday, August 11, 2020 6:38:58 PM

Post# of 34625
"The study is currently subject to a partial clinical hold on the use of a new reagent in the manufacturing process until the FDA reviews and accepts the final data and certificates of analysis for the new reagent. The alternate supplier has been delayed in providing the reagent but expects to ship the reagent to Marker in Q3."

WHAT TOTAL B.S.
Been talking about the Phase 2 AML trial for a year now ... and it is still .... just WAIT some more.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News